The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
IBD and pregnancy require careful planning. Women with IBD can have healthy pregnancies by managing their condition with ...
Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...
Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel ...
A recent study published in the journal Medicine has found a possible connection between low vitamin D levels and increased ...
A real-world study in adolescent and young adult patients with inflammatory bowel disease (IBD) found no significant ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...
Overall, the use of 5-aminosalicylic acid (5-ASA) in combination with ustekinumab (UST) did not provide a significant benefit in patients with inflammatory bowel disease (IBD). Evidence Rating Level: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback